Cirtran Financials
This page shows Cirtran (CIRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Cirtran passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Cirtran generates $0.02 in operating cash flow (-$46K OCF vs -$2.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Cirtran earns $-0.7 in operating income for every $1 of interest expense (-$551K vs $791K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Cirtran generated $1.3M in revenue in fiscal year 2024. This represents a decrease of 19.8% from the prior year.
Cirtran's EBITDA was -$546K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5148.8% from the prior year.
Cirtran reported -$2.6M in net income in fiscal year 2024. This represents a decrease of 112.9% from the prior year.
Cirtran earned $-0.53 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 112.9% from the prior year.
Cirtran had 5M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.
Cirtran's gross margin was 64.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 2.4 percentage points from the prior year.
Cirtran's operating margin was -42.5% in fiscal year 2024, reflecting core business profitability. This is down 41.6 percentage points from the prior year.
Cirtran's net profit margin was -202.6% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1457.9 percentage points from the prior year.
CIRX Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $448K+166.3% | $168K-63.4% | $461K+108.7% | $221K-43.4% | $390K-9.1% | $429K+141.6% | $178K-76.8% | $767K |
| Cost of Revenue | $271K+224.2% | $83K-56.2% | $191K+11624.4% | $2K-99.0% | $169K+6.8% | $158K+11.3% | $142K+26.5% | $112K |
| Gross Profit | $178K+109.3% | $85K-68.6% | $270K+23.3% | $219K-1.2% | $222K-18.3% | $271K+656.8% | $36K-94.5% | $654K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $201K+29.4% | $156K-15.7% | $185K-32.1% | $272K+42.7% | $191K-1.1% | $193K+167.7% | -$284K-156.3% | $505K |
| Operating Income | -$167K+13.8% | -$193K-346.6% | -$43K+77.0% | -$188K-99.2% | -$94K-103.1% | -$46K-120.0% | $232K+155420.8% | $149 |
| Interest Expense | $206K+1.5% | $203K+0.5% | $202K-11.8% | $229K+23.5% | $186K+0.4% | $185K-10.4% | $206K+7.2% | $192K |
| Income Tax | -$25K | N/A | $9K | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$420K+25.4% | -$563K-262.0% | -$155K+80.9% | -$813K-105.2% | -$396K+23.5% | -$518K-102.4% | $21.2M+10412.0% | -$206K |
| EPS (Diluted) | $-0.09+25.0% | $-0.12-300.0% | $-0.03+82.4% | $-0.17-112.5% | $-0.08+20.0% | $-0.10-102.3% | $4.29+10825.0% | $-0.04 |
CIRX Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M+16.8% | $1.6M-5.8% | $1.7M+13.8% | $1.5M-32.9% | $2.3M+21.6% | $1.9M+1.7% | $1.8M-12.4% | $2.1M |
| Current Assets | $1.7M+19.8% | $1.4M-6.8% | $1.5M+16.5% | $1.3M-35.1% | $2.0M+26.0% | $1.6M+2.1% | $1.5M-14.5% | $1.8M |
| Cash & Equivalents | $19K+344.6% | $4K+258.3% | $1K | N/A | N/A | $3K | N/A | $23K |
| Inventory | $714K-14.7% | $836K-0.6% | $842K+14.2% | $737K-8.1% | $802K-6.5% | $858K+5.2% | $816K-6.7% | $874K |
| Accounts Receivable | $55K+230.4% | $17K-86.9% | $128K+397.7% | $26K-77.2% | $112K+271.9% | $30K+40.1% | $22K-86.3% | $158K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $27.5M+2.6% | $26.8M+1.8% | $26.3M+1.4% | $25.9M+3.8% | $25.0M+3.3% | $24.2M+2.3% | $23.6M-47.6% | $45.1M |
| Current Liabilities | $24.6M+2.8% | $23.9M+1.9% | $23.5M+1.5% | $23.1M+4.3% | $22.2M+3.6% | $21.4M+2.5% | $20.9M-50.8% | $42.4M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$25.5M-1.7% | -$25.1M-2.3% | -$24.6M-0.6% | -$24.4M-7.5% | -$22.7M-1.8% | -$22.3M-2.4% | -$21.8M+49.3% | -$43.0M |
| Retained Earnings | -$62.8M-0.7% | -$62.4M-0.9% | -$61.8M-0.3% | -$61.6M-2.9% | -$59.9M-0.7% | -$59.5M-0.9% | -$59.0M+26.4% | -$80.2M |
CIRX Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$405K-154.9% | -$159K+66.1% | -$468K-1135.0% | -$38K-1013.7% | -$3K-122.6% | $15K+114.3% | -$106K-296.2% | $54K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$106K-296.2% | $54K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0 |
| Financing Cash Flow | $420K+159.2% | $162K-65.5% | $470K+1985.0% | $23K+5406.1% | $409+103.4% | -$12K-114.7% | $82K+224.4% | -$66K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CIRX Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.6%-10.8pp | 50.4%-8.2pp | 58.7%-40.6pp | 99.3%+42.4pp | 56.8%-6.4pp | 63.2%+43.0pp | 20.2%-65.2pp | 85.4% |
| Operating Margin | -37.1%+77.6pp | -114.7%-105.3pp | -9.4%+75.7pp | -85.0%-60.9pp | -24.1%-13.3pp | -10.8%-141.2pp | 130.4%+130.4pp | 0.0% |
| Net Margin | -93.6%+240.5pp | -334.1%-300.4pp | -33.7%+334.3pp | -368.0%-266.6pp | -101.4%+19.2pp | -120.7%-12059.6pp | 11939.0%+11965.8pp | -26.8% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -21.9%+12.4pp | -34.3%-25.4pp | -8.9%+44.1pp | -53.0%-35.7pp | -17.3%+10.2pp | -27.6%-1175.4pp | 1147.8%+1157.5pp | -9.8% |
| Current Ratio | 0.070.0 | 0.060.0 | 0.060.0 | 0.06-0.0 | 0.09+0.0 | 0.070.0 | 0.07+0.0 | 0.04 |
| Debt-to-Equity | -1.070.0 | -1.070.0 | -1.070.0 | -1.06+0.0 | -1.10-0.0 | -1.080.0 | -1.08-0.0 | -1.05 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | -59.4%-66.5pp | 7.0% |
Note: Shareholder equity is negative (-$24.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Cirtran's annual revenue?
Cirtran (CIRX) reported $1.3M in total revenue for fiscal year 2024. This represents a -19.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cirtran's revenue growing?
Cirtran (CIRX) revenue declined by 19.8% year-over-year, from $1.6M to $1.3M in fiscal year 2024.
Is Cirtran profitable?
No, Cirtran (CIRX) reported a net income of -$2.6M in fiscal year 2024, with a net profit margin of -202.6%.
What is Cirtran's earnings per share (EPS)?
Cirtran (CIRX) reported diluted earnings per share of $-0.53 for fiscal year 2024. This represents a -112.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Cirtran's EBITDA?
Cirtran (CIRX) had EBITDA of -$546K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Cirtran's gross margin?
Cirtran (CIRX) had a gross margin of 64.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Cirtran's operating margin?
Cirtran (CIRX) had an operating margin of -42.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Cirtran's net profit margin?
Cirtran (CIRX) had a net profit margin of -202.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Cirtran's operating cash flow?
Cirtran (CIRX) generated -$46K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Cirtran's total assets?
Cirtran (CIRX) had $1.5M in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Cirtran have outstanding?
Cirtran (CIRX) had 5M shares outstanding as of fiscal year 2024.
What is Cirtran's current ratio?
Cirtran (CIRX) had a current ratio of 0.06 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Cirtran's debt-to-equity ratio?
Cirtran (CIRX) had a debt-to-equity ratio of -1.06 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cirtran's return on assets (ROA)?
Cirtran (CIRX) had a return on assets of -171.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Why is Cirtran's debt-to-equity ratio negative or unusual?
Cirtran (CIRX) has negative shareholder equity of -$24.4M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Cirtran's Piotroski F-Score?
Cirtran (CIRX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Cirtran's earnings high quality?
Cirtran (CIRX) has an earnings quality ratio of 0.02x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Cirtran cover its interest payments?
Cirtran (CIRX) has an interest coverage ratio of -0.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.